The Center for Medicare and Medicaid Innovation today announced a new payment model for Medicare Part D and Medicare Advantage drug plans beginning January 2020, which will test new incentives for plans, patients and providers to choose drugs with lower list prices. Plans participating in the voluntary five-year model will take on greater risk for spending in the catastrophic phase of Part D and share in any resulting savings to federal reinsurance subsidy costs. The model also includes a Part D rewards and incentives program and other tools to help plans control drug costs and enrollees choose drugs with lower list prices. Also today, the Centers for Medicare & Medicaid Services announced changes to the MA Value-Based Insurance Design model for calendar year 2020, which will allow plans to provide reduced cost sharing and additional supplemental benefits to enrollees based on condition and/or socioeconomic status; bolster rewards and incentives for beneficiaries to improve their health; and increase access to telehealth services. 
 

Related News Articles

Headline
The Government Accountability Office today named three new members to the Medicare Payment Advisory Commission through April 2023. They are: Wayne…
Headline
The Centers for Medicare & Medicaid Services yesterday released early stakeholder insights from its Accountable Health Communities Model. The model tests…
Headline
The Centers for Medicare & Medicaid Services May 7 issued a final rule that implements the standards governing health insurance issuers and the Health…
Headline
AHA yesterday urged the Federal Communications Commission to grant expedited approval to its request that the agency extend the COVID-19 Telehealth Program to…
Headline
A federal district court in Washington, D.C., today heard oral argument in the AHA’s legal challenge to the Centers for Medicare & Medicaid Services’ final…
Headline
The Health Resources and Services Administration this week hosted webinars for health care providers on the agency’s COVID-19 Uninsured Program Portal. During…